ORCL · News · 20261020N

Products and Technology — Oracle Health AI

ORACLE CORP · 2026-10-20 · Importance 31 · Surprise 42

Oracle and AstraZeneca entered a nonbinding agreement to explore AI and real-world data applications in clinical research and patient care. The collaboration is intended to identify eligible clinical-trial participants sooner, accelerate evidence generation, and connect research insights with care workflows. Initial therapeutic areas include oncology, cardiovascular, renal and metabolic diseases, respiratory and immunology, and rare diseases. The companies expect work to span the United States, Middle East, and Europe and to cover clinical-trial enrollment, diagnosis, drug-safety monitoring, and future study design.